S. Jezdic

3.4k total citations · 2 hit papers
15 papers, 795 citations indexed

About

S. Jezdic is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. Jezdic has authored 15 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pediatrics, Perinatology and Child Health and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. Jezdic's work include Childhood Cancer Survivors' Quality of Life (5 papers), Cancer Genomics and Diagnostics (3 papers) and Adolescent and Pediatric Healthcare (3 papers). S. Jezdic is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (5 papers), Cancer Genomics and Diagnostics (3 papers) and Adolescent and Pediatric Healthcare (3 papers). S. Jezdic collaborates with scholars based in Italy, Germany and France. S. Jezdic's co-authors include Joaquı́n Mateo, Lajos Pusztai, Fabrice André, Abel González-Pérez, Charlotte K.Y. Ng, Debyani Chakravarty, Eliezer M. Van Allen, Rodrigo Dienstmann, Núria López-Bigas and J.-Y. Douillard and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Expert Review of Anticancer Therapy.

In The Last Decade

S. Jezdic

15 papers receiving 782 citations

Hit Papers

A framework to rank genomic alterations as targets for ca... 2018 2026 2020 2023 2018 2021 100 200 300

Peers

S. Jezdic
Comparison fields: 5 of 71
  • Cancer Research 319
  • Oncology 316
  • Pulmonary and Respiratory Medicine 233
  • Pediatrics, Perinatology and Child Health 168
  • Molecular Biology 144
Replace Laurence Vanlemmens with:
Laurence Vanlemmens France
Kerstin Rhiem Germany
L. Phuong United States
Michaela L. Tsai United States
Weijiang Liang China
Hamdy A. Azim Egypt
Elisa Dama Italy
Sileny Han Belgium
Jessica N. Everett United States
Ray Snyder Australia
Laurence Vanlemmens France View profile →
Citations per field, relative to S. Jezdic
S. Jezdic · 1×
Citations per year, relative to S. Jezdic
S. Jezdic · 1×

Countries citing papers authored by S. Jezdic

Since Specialization
Citations

This map shows the geographic impact of S. Jezdic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Jezdic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Jezdic more than expected).

Fields of papers citing papers by S. Jezdic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Jezdic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Jezdic. The network helps show where S. Jezdic may publish in the future.

Co-authorship network of co-authors of S. Jezdic

This figure shows the co-authorship network connecting the top 25 collaborators of S. Jezdic. A scholar is included among the top collaborators of S. Jezdic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Jezdic. S. Jezdic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
# Work Indexed citations
1 1
2 35
3 63
4 32
5 5
6 2
7
Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE) breakdown →
138
8 20
9
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) breakdown →
391
10 2
11 44
12 4
13 3
14 43
15
Biweekly oxaliplatin, fluorouracil and leucovorin versus cisplatin, fluorouracil and leucovorin in patients with advanced gastric cancer.
12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026